Transcranial magnetic stimulation (TMS) is a noninvasive brain stimulation therapy primarily used to treat major depression that hasn’t responded to medication. It’s also FDA-cleared for obsessive-compulsive disorder, migraines, and smoking cessation. The treatment works by delivering magnetic pulses to specific areas of the brain, changing how nerve cells fire in regions linked to mood, impulse control, and pain.
How TMS Works
During a TMS session, an electromagnetic coil placed against your scalp generates rapid magnetic pulses that pass through the skull and activate nerve cells in targeted brain regions. For depression, the target is typically the left dorsolateral prefrontal cortex, a region involved in mood regulation. The pulses trigger real, lasting changes in how brain cells communicate with each other, a process called neuroplasticity.
At the cellular level, TMS activates signaling pathways that strengthen connections between neurons. The magnetic pulses cause brain cells to release calcium and ramp up production of a growth factor (BDNF) that helps neurons form stronger, more efficient connections. This is essentially the same biological mechanism your brain uses to learn and form memories, but TMS directs it toward underactive circuits. Different pulse patterns can either increase or decrease activity in the targeted region, which is why the same basic technology can be applied to very different conditions.
Treatment-Resistant Depression
Depression is by far the most common reason people receive TMS. The FDA first cleared it for major depressive disorder in patients who had failed at least one antidepressant medication. In practice, most people who try TMS have already been through several medications without adequate relief.
Response rates are meaningful but not universal. In clinical studies, roughly 40 to 45 percent of patients showed a significant reduction in depression symptoms, and about 17 to 22 percent achieved full remission. Those numbers may sound modest, but these are patients for whom standard antidepressants had already failed. For that population, a one-in-five chance of complete remission represents a real option.
A standard course of TMS for depression involves daily sessions, five days a week, for four to six weeks. The traditional protocol takes about 37.5 minutes per session. A newer approach called intermittent theta burst stimulation (iTBS), cleared by the FDA in 2018, delivers the same therapeutic effect in just over three minutes per session. Studies have found the three-minute protocol produces similar changes in brain plasticity as the longer version, which makes the treatment far more practical for people with work or family obligations.
Obsessive-Compulsive Disorder
OCD was the second major psychiatric condition to receive FDA clearance for TMS treatment. The approach uses a specialized “deep TMS” coil designed to reach structures further below the brain’s surface than standard TMS can. The target is different from depression treatment: deep TMS for OCD modulates a circuit running between the cortex, a deep brain structure called the striatum, and the thalamus. Specifically, it works by increasing activity in the anterior cingulate cortex, a region involved in error monitoring and decision-making that functions abnormally in OCD.
In the randomized controlled trial that led to FDA clearance, 38 percent of patients responded to treatment, with effects sustained for at least four weeks. Real-world clinical data has been even more encouraging, with 52.4 percent of patients achieving a sustained response lasting at least one month. As with depression, TMS for OCD is typically reserved for people who haven’t found enough relief from therapy and medication alone.
Smoking Cessation
TMS is FDA-cleared as an aid to short-term smoking cessation, making it the first non-drug, non-nicotine-replacement tool approved for quitting. The treatment protocol involves daily sessions five days a week for three weeks, followed by three once-a-week sessions.
In the pivotal clinical trial of 262 participants, 17.1 percent of people in the TMS group maintained a continuous four-week quit compared to 7.9 percent in the placebo group. Among participants who kept detailed smoking diaries, the difference was sharper: 27.3 percent quit rates with TMS versus 11.3 percent with sham treatment. People in the active treatment group also smoked significantly fewer cigarettes per day even if they didn’t quit entirely. These numbers won’t replace willpower and behavioral support, but they represent a statistically meaningful boost for people struggling to quit.
Migraines
The FDA has also cleared TMS for migraines, using single-pulse (rather than repetitive) stimulation. In studies, people who averaged about nine headache days per month saw that number drop by roughly three days after TMS treatment. A National Institutes of Health study confirmed that TMS reduces both the frequency and severity of migraines. The evidence base is smaller than for depression, but the available data points toward TMS being a safe, drug-free option for people with chronic migraines who want to reduce their reliance on medication.
Uses Still Being Studied
Beyond its FDA-cleared indications, TMS is being used and investigated for several other conditions. Deep TMS has received European regulatory clearance (CE certification) for both PTSD and chronic pain, though it hasn’t yet received FDA approval for those uses in the United States. Clinicians sometimes use TMS off-label for generalized anxiety, often treating it alongside depression with the same protocol. Research is also exploring applications in eating disorders, where TMS may help reduce the anxiety and depressive symptoms that fuel disordered eating behaviors.
What a Treatment Course Looks Like
TMS is an outpatient procedure. You sit in a chair, awake and alert, while a technician positions the magnetic coil against your head. There’s no anesthesia, no sedation, and no recovery time. You can drive yourself to and from appointments and return to normal activities immediately after each session.
During your first visit, the clinician determines your “motor threshold,” the minimum magnetic pulse strength needed to make your thumb twitch. This calibrates the machine to your individual brain. Treatment sessions then follow a set protocol depending on the condition being treated. For depression, that’s typically 20 to 30 sessions over four to six weeks with the traditional protocol, or the same number of sessions using the faster three-minute theta burst approach.
Side Effects and Safety
TMS has a favorable safety profile compared to most psychiatric medications. The most common side effect is headache, reported by about 20 to 32 percent of patients in clinical trials. The second most common is discomfort or mild pain at the stimulation site, affecting roughly 18 to 36 percent of patients depending on the study. Both tend to be mild and typically decrease over the course of treatment as your scalp adjusts to the sensation.
It’s worth noting that sham (placebo) TMS also produces headaches in 10 to 23 percent of patients, meaning some of the headache effect comes simply from sitting with a device on your head. The gap between real and sham side effects is relatively small, which underscores how well-tolerated the treatment is. Seizure is a theoretical risk but extremely rare. People with metal implants in or near the head, cochlear implants, or implanted stimulators are generally not candidates for TMS because the magnetic field can interact with metal objects.